NonamplificationERBB2genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies-Reference-Cited by-同舟云学术

NonamplificationERBB2genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies

Published:2016-06-10 Issue:17 Volume:122 Page:2654-2662
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ross Jeffrey S.¹²,Gay Laurie M.¹^ORCID,Wang Kai¹³,Ali Siraj M.¹,Chumsri Saranya⁴,Elvin Julia A.¹,Bose Ron⁵,Vergilio Jo-Anne¹,Suh James¹,Yelensky Roman¹,Lipson Doron¹,Chmielecki Juliann¹,Waintraub Stanley⁶,Leyland-Jones Brian⁷,Miller Vincent A.¹,Stephens Philip J.¹

Affiliation:

1. Foundation Medicine Inc; Cambridge Massachusetts

2. Department of Pathology; Albany Medical College; Albany New York

3. Department of Computational Biology; Zhejiang Cancer Hospital; Hangzhou China

4. Department of Hematology/Oncology; Mayo Clinic; Jacksonville Florida

5. Division of Oncology; Department of Medicine, Washington University School of Medicine; St. Louis Missouri

6. Department of Breast Oncology; Hackensack University Medical Center; Hackensack New Jersey

7. Department of Hematology/Oncology; Avera Health; Sioux Falls South Dakota

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen;Schechter;Nature,1984

2. The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine;Ross;Oncologist,2009

3. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization;Kallioniemi;Proc Natl Acad Sci USA,1992

4. The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis;Moasser;Oncogene,2007

5. Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer;Prat;J Natl Cancer Inst,2014

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-type agnostic, targeted therapies make a new step forward: The first tumor-agnostic approval of a HER2-targeted therapy;Biomolecules and Biomedicine;2024-07-28

2. HER2 mutation as an emerging target in advanced breast cancer;Cancer Science;2024-05-07

3. Ganz-Exom-Sequenzierung zur Bestimmung zielgerichteter Therapien für Patientinnen mit metastasiertem Mammakarzinom – eine Machbarkeitsstudie;Senologie - Zeitschrift für Mammadiagnostik und -therapie;2024-03

4. Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer;Molecular Oncology;2024-01-29

5. Personalized Medicine in Clinical Management of Breast Cancer: Where Do We Stand?;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024